Drugs Made In America Acquisition II Corp. Right (DMIIR) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jul 24Jul 29Aug 10Aug 14Aug 20Aug 25Aug 31Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−4.1x

Market Cap

$5.24M

MomentumView details →

1D Return

+14.14%

YTD Return

−50.00%

RSI (14)

43.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−4.1x

Market Cap

$5.24M

RSI (14)

43.8

MomentumView details →

1D Return

+14.14%

YTD Return

−50.00%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

2.62%

ROA (TTM)

2.53%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+2808.33%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

0.34x

Quick Ratio

0.34x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

13.02M

Op. CF (TTM)

—

Latest newsMore news →

No recent news for DMIIR.

Similar companies

CaliberCos Inc.CWD Galata Acquisition Corp. IILATAW LightWave Acquisition Corp.LWACW TaoWeave, Inc.TWAV CSLM Digital Asset Acquisition Corp III WarrantsKOYNW McKinley Acquisition Corporation RightsMKLYR Find similar companies →

Latest newsMore news →

No recent news for DMIIR.